Jae-Won Hyun
Overview
Explore the profile of Jae-Won Hyun including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
981
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim S, Min J, Kim S, Lee E, Lim Y, Shin H, et al.
J Clin Neurol
. 2025 Mar;
21(2):131-136.
PMID: 40065454
Background And Purpose: Treatments for neuromyelitis optica spectrum disorder (NMOSD) such as eculizumab, ravulizumab, satralizumab, and inebilizumab have significantly advanced relapse prevention, but they remain expensive. Rituximab is an off-label...
2.
Hyun J, Kim S, Moon J, Park N, Kang Y, Kim K, et al.
Neurol Neuroimmunol Neuroinflamm
. 2025 Feb;
12(3):e200366.
PMID: 40020215
Background And Objectives: Association of human leukocyte antigen (HLA) with anti-aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder (AQP4-IgG NMOSD) has been reported. However, this association in the Korean population has...
3.
Kim S, Gomes A, Schindler P, Hyun J, Kim K, Lee D, et al.
JAMA Neurol
. 2024 Dec;
82(2):168-175.
PMID: 39714824
Importance: The temporal dynamics of serum glial fibrillary acidic protein (sGFAP) and serum neurofilament light chain (sNfL) as biomarkers of disease activity for neuromyelitis optica spectrum disorder (NMOSD) remain underexplored....
4.
Gomes A, Kim S, Pretzsch R, Kulsvehagen L, Schaedelin S, Lerner J, et al.
Neurol Neuroimmunol Neuroinflamm
. 2024 Dec;
12(1):e200347.
PMID: 39705633
Background And Objectives: In patients with myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD), acute disease activity is generally identified through medical history, neurologic examination, and imaging. However, these may be...
5.
Kang Y, Kim K, Hyun J, Kim S, Kim H
Mult Scler Relat Disord
. 2024 Sep;
91:105859.
PMID: 39236649
Background: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is an inflammatory disease affecting the central nervous system that may require long-term immunotherapy in relapsing cases. While immunotherapies utilized in neuromyelitis optica...
6.
Kim S, Ahn B, Lee D, Kim K, Hyun J, Kim M, et al.
Int J Mol Sci
. 2024 Jun;
25(12).
PMID: 38928104
The diagnosis of brain metastases (BMs) in patients with lung cancer (LC) predominantly relies on magnetic resonance imaging (MRI), a method that is constrained by high costs and limited accessibility....
7.
Kim K, Chung Y, Min J, Han H, Kim S, Shin H, et al.
J Neurol Neurosurg Psychiatry
. 2024 May;
95(12):1168-1175.
PMID: 38777578
Background: The risk-benefit relationship of immunosuppressive therapies (ISTs) for elderly patients with neuromyelitis optica spectrum disorder (NMOSD) is not well established. This study aimed to investigate the safety and efficacy...
8.
Kim K, Park M, Park E, Gwak H, Kim S, Seo J, et al.
Neurology
. 2024 Feb;
102(5):e209167.
PMID: 38364192
Background And Objectives: Leptomeningeal metastases (LMs) are neoplasms that proliferate to membranes lining the brain and spinal cord. Intra-CSF methotrexate (MTX) chemotherapy is a prevalent treatment option. However, resultant long-term...
9.
Kang S, Park H, Hyun J, Gwak H
Brain Tumor Res Treat
. 2024 Feb;
12(1):58-62.
PMID: 38317489
Differential diagnosis of focal brainstem lesions detected on MRI is challenging, especially in young children. Formerly, brainstem gliomas were classified mainly based on MRI features and location. However, since 2016,...
10.
Kim K, Kim S, Park N, Kim M, Hyun J, Kim H
Mult Scler Relat Disord
. 2023 Dec;
81:105145.
PMID: 38039942
Background: Latent tuberculosis infection (LTBI) is defined as an immune response to Mycobacterium tuberculosis infection that does not manifest clinically as active tuberculosis (TB). Since some immunotherapies can alter cellular...